MEDX HEALTH CORP (MDX.CA) Stock Income Statement
TSX-V:MDX - TSX Venture Exchange - CA5850901037 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 494.00K | 489.70K | 456.10K | 510.60K | 563.10K | |||
| Cost Of Goods | 284.00K | 295.50K | 270.50K | 270.70K | 289.80K | |||
| Gross Profit | 210.10K | 194.20K | 185.60K | 240.00K | 273.30K | |||
| Operating Expenses | 2.96M | 2.50M | 3.21M | 4.11M | 4.84M | |||
| Research and Development | 507.30K | 526.30K | 586.10K | 681.80K | 995.40K | |||
| Selling, General, and Administrative Expenses | 2.69M | 1.94M | 2.59M | 3.39M | 3.81M | |||
| Operating Income | -2.75M | -2.30M | -3.02M | -3.87M | -4.56M | |||
| Interest Income/Expense | -1.57M | -1.35M | -2.15M | -1.27M | -784.20K | |||
| Non Recurring Items | N/A | 0.00 | 597.80K | 0.00 | 23.40K | |||
| Income Before Taxes | -4.32M | -3.65M | -4.58M | -5.13M | -5.32M | |||
| Net Income | -4.32M | -3.65M | -4.58M | -5.13M | -5.32M | |||
| EBITDA | -2.71M | -2.26M | -2.97M | -3.82M | -4.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.02 | -0.03 | -0.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 42.53% | 39.66% | 40.69% | 47.00% | 48.53% | |||
| Profit Margin | -875.14% | -745.97% | -1004.30% | -1005.42% | -945.39% | |||
| Operating Profit Margin | -557.59% | -470.45% | -663.23% | -757.62% | -810.30% | |||
All data in CAD